Most Americans And Canadians With HIV Diagnosed Too Late

Most Americans And Canadians With HIV Diagnosed Too Late.

Americans and Canadians infected with HIV are not getting diagnosed shortly enough after exposure, resulting in a potentially poisonous stall in lifesaving treatment, a new large study suggests. The observation stems from an criticism involving nearly 45000 HIV-positive patients in both countries, which focused on a key yardstick for inoculated system strength - CD4 cell counts - at the time each patient word go began treatment look at this. CD4 counts measure the number of "helper" T-cells that are HIV's preferred target.

Reviewing the participants' medical records between 1997 and 2007, the gang found that throughout the 10-year study period, the undistinguished CD4 count at the time of first treatment was below the recommended level that scientists have prolonged identified as the ideal starting point for medical care. "The public health implications of our findings are clear," go into author Dr Richard Moore, from the Johns Hopkins University School of Medicine in Baltimore, said in a flash release. "Delayed diagnosis reduces survival, and individuals enter into HIV charge with lower CD4 counts than the guidelines for initiating antiretroviral therapy" A put on hold in getting treatment not only increases the chance that the disease will progress, but boosts the risk of transmission.

Despite the experience that the average CD4 count at time of first presentation to care had risen over the tack of the decade from 256 to 317, the researchers noted that even the high point was still below the treatment threshold of 350. Moore and his crew also found that the average age at which patients had first sought care for HIV had risen over the ten-year period, from 40 to 43.

Writing in an article that accompanied the study, Dr Cynthia Gay of the University of North Carolina at Chapel Hill expressed bother over the findings. "These findings display that despite such compelling data, there is much room for improving our ability to link more HIV-infected individuals with functional treatment prior to immunological deterioration," she said in a news release view website. Moore and his colleagues promulgate their findings in the June 1 issue of Clinical Infectious Diseases.

tag : treatment findings counts moore first study average risen university

Post a comment

Private comment



Dr. Alejandra Falto

Новые записи
Новые комментарии
Новые трэкбэки
Архив по месяцам
Форма поиска
RSS ссылка
Формуляр приглашения в блог-друзья

Добавить автора в блог-друзья